Αποτελέσματα Αναζήτησης
The use of formocresol for vital pulp therapy has been under considerable debate due to its formaldehyde component [35,36]. A study comparing DPC using formocresol with conventional CH capping, has reported better success rates with the former material and suggested it to substitute the conventional method [37].
- Pulpotomy - an overview | ScienceDirect Topics
Electrosurgery uses radiofrequency energy to produce a...
- Pulpotomy - an overview | ScienceDirect Topics
3 Μαΐ 2023 · Due to concerns about formocresol's mutagenic and genotoxic potential, its use as a pulpotomy medication is currently debatable. The current paper aimed to review the properties of formocresol...
Formacresol is a mixture consisting of formalin, cresol and glycerine used in dentistry. [1] It is used for vital pulpotomy of primary teeth and as a temporary intracanal medicament during root canal therapy.
Formocresol has been used in dentistry for over 100 years, and for vital pulpotomy in primary teeth for over 80 years. Its efficacy has been extensively studied, with clinical success rates ranging from 70% to 100%, making it the standard against which newer techniques are compared.
10 Μαΐ 2008 · Formocresol interferes with healing. As recently as March 2008 research has shown that formocresol causes genetic damage. I urge dentists to rethink their use of formocresol.
Buckley introduced formocresol in 1904, which is the most commonly used medicament for pulpotomy. The success rate of formocresol pulpotomy ranged from 70 to 98%. 6 Histological findings observed with the use of formocresol ranged from slight inflammation to total degeneration and necrotic changes.
Formocresol has been used in dentistry since 100 years. The biologic approach to pediatric pulp therapy is either devitalization approach of formocresol pulptomy or pulpectomy. Formocresol was introduced to treat non-vital permanent teeth in the United States by Buckley in 1904. In 1930, Sweet introduced the formocresol pulpotomy
